APELLIS PHARMACEUTICALS INC (APLS) Stock Earnings Estimates
NASDAQ:APLS • US03753U1060
22.28 USD
-0.52 (-2.28%)
At close: Feb 20, 2026
22.28 USD
0 (0%)
After Hours: 2/20/2026, 8:17:07 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 75.4M 13.21% | 396.591M 425.98% | 781.367M 97.02% | 1.026B 31.31% | 883.75M -13.86% | 1.039B 17.57% | 1.281B 23.29% | 1.43B 11.63% | 1.609B 12.52% | 1.736B 7.89% | 1.894B 9.10% | 2.015B 6.39% | |
| EBITDA YoY % growth | -593.05M -10.87% | -515.337M 13.10% | -163.182M 68.33% | 68.706M 142.10% | -63.274M -192.09% | 90.969M 243.77% | 235.19M 158.54% | 297.35M 26.43% | 506.41M 70.31% | 588.31M 16.17% | 803.57M 36.59% | 1.035B 28.80% | |
| EBIT YoY % growth | -594.6M -10.87% | -517.121M 13.03% | -164.979M 68.10% | 66.087M 140.06% | -121.988M -284.59% | 8.377M 106.87% | 154.7M 1,746.72% | 256.48M 65.79% | 395.65M 54.26% | 565.23M 42.86% | 683.11M 20.86% | 697.11M 2.05% | |
| Operating Margin | -788.59% | -130.39% | -21.11% | 6.44% | -13.80% | 0.81% | 12.08% | 17.94% | 24.59% | 32.56% | 36.07% | 34.60% | |
| EPS YoY % growth | -6.13 31.35% | -4.48 26.92% | -1.45 67.63% | 0.22 115.15% | -1.15 -623.12% | -0.23 79.84% | 0.85 468.43% | 1.58 85.34% | 2.73 72.27% | 3.01 10.45% | 3.52 16.94% | 4.02 14.29% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 -34.30% | -0.48 34.46% | -0.35 -7.56% | -0.29 -117.41% | -0.20 47.62% | -0.16 66.35% | 0.11 131.61% | 0.21 173.68% | 0.33 260.00% |
| Revenue Q2Q % growth | 203.21M -4.38% | 195.22M 17.04% | 213.5M 19.61% | 226.29M -50.65% | 250.56M 23.30% | 247.91M 26.99% | 286.21M 34.06% | 305.52M 35.01% | 328.73M 31.20% |
| EBITDA Q2Q % growth | -42.8M -75.65% | -61.486M 25.81% | -45.834M -41.49% | -30.159M -113.44% | -36.923M 13.73% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -42.886M -63.91% | -53.974M 35.23% | -40.41M -21.40% | -28.879M -112.94% | -11.683M 72.76% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.67 463.04% | 1.21 | 0.46 | 38.10% |
| Q2 2025 Q2Q % growth | -0.33 -17.86% | -0.48 | 0.15 | 31.03% |
| Q1 2025 Q2Q % growth | -0.74 -76.19% | -0.37 | -0.37 | -101.36% |
| Q4 2024 Q2Q % growth | -0.29 60.27% | -0.39 | 0.10 | 26.26% |
| Q3 2024 Q2Q % growth | -0.46 60.68% | -0.31 | -0.15 | -50.27% |
| Q2 2024 Q2Q % growth | -0.28 72.55% | -0.33 | 0.05 | 15.16% |
| Q1 2024 Q2Q % growth | -0.42 73.08% | -0.48 | 0.06 | 11.77% |
| Q4 2023 Q2Q % growth | -0.73 51.33% | -0.70 | -0.03 | -4.28% |
| Q3 2023 Q2Q % growth | -1.17 33.14% | -0.87 | -0.30 | -34.09% |
| Q2 2023 Q2Q % growth | -1.02 30.14% | -1.35 | 0.33 | 24.40% |
| Q1 2023 Q2Q % growth | -1.56 -9.86% | -1.49 | -0.07 | -4.46% |
| Q4 2022 Q2Q % growth | -1.50 6.83% | -1.60 | 0.10 | 6.20% |
| Q3 2022 Q2Q % growth | -1.75 23.25% | -1.48 | -0.27 | -17.99% |
| Q2 2022 Q2Q % growth | -1.46 46.32% | -1.39 | -0.07 | -4.87% |
| Q1 2022 Q2Q % growth | -1.42 38.79% | -1.35 | -0.07 | -5.49% |
| Q4 2021 Q2Q % growth | -1.61 -273.12% | -1.57 | -0.04 | -2.63% |
| Q3 2021 Q2Q % growth | -2.28 -27.37% | -1.73 | -0.55 | -31.79% |
| Q2 2021 Q2Q % growth | -2.72 -73.25% | -1.72 | -1.00 | -58.19% |
| Q1 2021 Q2Q % growth | -2.32 -1.31% | -1.62 | -0.70 | -43.34% |
| Q4 2020 Q2Q % growth | 0.93 | -0.77 | 1.70 | 221.15% |
| Q3 2020 Q2Q % growth | -1.79 | -1.61 | -0.18 | -11.07% |
| Q2 2020 Q2Q % growth | -1.57 | -1.36 | -0.21 | -15.26% |
| Q1 2020 Q2Q % growth | -2.29 | -1.41 | -0.88 | -62.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 458.578M 132.98% | 414.81M | 43.768M | 10.55% |
| Q2 2025 Q2Q % growth | 178.494M -10.61% | 192.29M | -13.796M | -7.17% |
| Q1 2025 Q2Q % growth | 166.797M -3.21% | 199.52M | -32.723M | -16.40% |
| Q4 2024 Q2Q % growth | 212.528M 45.19% | 202.32M | 10.208M | 5.05% |
| Q3 2024 Q2Q % growth | 196.83M 78.29% | 204.36M | -7.53M | -3.68% |
| Q2 2024 Q2Q % growth | 199.685M 110.26% | 194.9M | 4.785M | 2.46% |
| Q1 2024 Q2Q % growth | 172.325M 284.26% | 166.62M | 5.705M | 3.42% |
| Q4 2023 Q2Q % growth | 146.377M 544.83% | 146.47M | -93K | -0.06% |
| Q3 2023 Q2Q % growth | 110.399M 399.54% | 101.04M | 9.359M | 9.26% |
| Q2 2023 Q2Q % growth | 94.969M 482.63% | 71.657M | 23.312M | 32.53% |
| Q1 2023 Q2Q % growth | 44.846M 211.43% | 26.625M | 18.221M | 68.44% |
| Q4 2022 Q2Q % growth | 22.7M -62.35% | 24.921M | -2.221M | -8.91% |
| Q3 2022 Q2Q % growth | 22.1M 287.72% | 22.025M | 75K | 0.34% |
| Q2 2022 Q2Q % growth | 16.3M 2,616.67% | 17.283M | -983K | -5.69% |
| Q1 2022 Q2Q % growth | 14.4M | 12.824M | 1.576M | 12.29% |
| Q4 2021 Q2Q % growth | 60.3M -75.88% | 8.96M | 51.34M | 572.99% |
| Q3 2021 Q2Q % growth | 5.7M 850.00% | 7.37M | -1.67M | -22.66% |
| Q2 2021 Q2Q % growth | 600K | 509.918K | 90.082K | 17.67% |
| Q1 2021 Q2Q % growth | 2.318M | -2.318M | -100.00% | |
| Q4 2020 Q2Q % growth | 250M | 98.008M | 151.992M | 155.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.32% | -11.59% | -10.52% | 1000.08% |
| Revenue | 0.07% | -2.52% | 1.89% | 4.72% |